International Assets Investment Management, LLC Neurocrine Biosciences Inc Transaction History

International Assets Investment Management, LLC

$36.5 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$130.86 - $143.19 $2,224 - $2,434	17 New	17 $2.34 Million
Q4 2023 Jan 24, 2024	BUY	$106.07 - $132.76 $600,992 - $752,218	5,666 New	5,666 $43,000
Q3 2023 Oct 04, 2023	BUY	$94.02 - $117.1 $6,675 - $8,314	71 New	71 $7,000
Q2 2021 Jul 14, 2021	SELL	$89.43 - $102.27 $715 - $818	-8 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$86.91 - $108.33 $695 - $866	8 New	8 $767,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account